Male infertility. Male infertility
Conditions
Interventions
Intervention 1: Intervention group: Routine infertility treatment plus Q10 coenzyme capsule (CO-Q 10) (manufactured by Nature Mid Pharmaceuticals) 30 mg daily for 12 weeks. Intervention 2: Control gro
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
15 Years to 40 Years
Inclusion criteria
Inclusion criteria: Age of 18 to 40 years, Man with primary infertility, Abnormality in at least one of the sperm parameters (volume, concentration, number, motility, or morphology), Body mass index less than 30,
Exclusion criteria
Exclusion criteria: Chromosomal abnormalities, Varicocele, Cryptorchidism, Chronic diseases such as diabetes, kidney disease, infectious diseases, genital tract infection, thyroid disorder, Drug or alcohol use, Taking spermatogenic drugs (methotrexate, nitrofurantoin, colchicine or chemotherapy), Taking pituitary suppressive drugs (testosterone, GnRh analogs), Taking anti-androgens (cimetidine or spironolactone), Taking alpha-blockers, antidepressants, or phenothiazide, History of testis surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sperm volume. Timepoint: Before and 12 weeks after the intervention. Method of measurement: By spermogram analysis.;Sperm count. Timepoint: Before and 12 weeks after the intervention. Method of measurement: By spermogram analysis.;Sperm concentration. Timepoint: Before and 12 weeks after the intervention. Method of measurement: By spermogram analysis.;Sperm motility. Timepoint: Before and 12 weeks after the intervention. Method of measurement: By spermogram analysis.;Sperm morphology. Timepoint: Before and 12 weeks after the intervention. Method of measurement: By spermogram analysis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTaiebeh Gharakhani
Hamedan University of Medical Sciences
Outcome results
None listed